(Q43073121)

English

Trastuzumab beyond progression: a cost-utility analysis.

scientific article published on 5 May 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

title

Trastuzumab beyond progression: a cost-utility analysis (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Klazien Matter-Walstra

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

Matthias Schwenkglenks

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

author name string

K J Dedes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

P Brauchli

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

T D Szucs

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

B C Pestalozzi

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

publication date

5 May 2010

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

volume

21

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

issue

11

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

page(s)

2161-2168

1 reference

stated in

Europe PubMed Central

PubMed ID

20444849

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20444849%20AND%20SRC:MED&resulttype=core&format=json

(Q43073121)

Trastuzumab beyond progression: a cost-utility analysis.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)